| 1 | [SID51090468] | Active | EC50 | 0.088 | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Infection [AID2294, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | EC50 | 0.088 [uM] | | BioAssay | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Infection | | AID | 2294 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID51090468] | Active | EC50 | 0.1 | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. [AID2044, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | EC50 | 0.1 [uM] | | BioAssay | Luminescence Cell-Based/Microorganism Dose Confirmation HTS to Identify Inhibitors of T.Cruzi Replication. | | AID | 2044 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID51090468] | Active | Potency | 1.7783 | qHTS Assay for Rab9 Promoter Activators [AID485297, Type: confirmatory] | RAB9A gene product [Homo sapiens] [gi:4759012] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | Potency | 1.7783 [uM] | | BioAssay | qHTS Assay for Rab9 Promoter Activators | | AID | 485297 | | BioAssay type | confirmatory | | Target | RAB9A gene product [Homo sapiens] [gi:4759012] | | PubMed | | | Data Table |  |
|
| 4 | [SID51090468] | Active | Potency | 2.8184 | qHTS Assay for NPC1 Promoter Activators [AID485313, Type: confirmatory] | NPC1 gene product [Homo sapiens] [gi:255652944] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | Potency | 2.8184 [uM] | | BioAssay | qHTS Assay for NPC1 Promoter Activators | | AID | 485313 | | BioAssay type | confirmatory | | Target | NPC1 gene product [Homo sapiens] [gi:255652944] | | PubMed | | | Data Table |  |
|
| 5 | [SID51090468] | Active | Potency | 3.6611 | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 [AID504466, Type: confirmatory] | ATAD5 protein [Homo sapiens] [gi:116283940] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | Potency | 3.6611 [uM] | | BioAssay | qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1 | | AID | 504466 | | BioAssay type | confirmatory | | Target | ATAD5 protein [Homo sapiens] [gi:116283940] | | PubMed | | | Data Table |  |
|
| 6 | [SID51090468] | Active | Potency | 10 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 7 | [SID51090468] | Active | Potency | 13.4591 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | Potency | 13.4591 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 8 | [SID51090468] | Active | Potency | 50.1187 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 9 | [SID51090468] | Active | Potency | 70.7946 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | Potency | 70.7946 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 10 | [SID51090468] | Active | Potency | 70.7946 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | Potency | 70.7946 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 11 | [SID51090468] | Active | Potency | 70.7946 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | Potency | 70.7946 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 12 | [SID51090468] | Active | Potency | 70.7946 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | Potency | 70.7946 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 13 | [SID51090468] | Active | | | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652010, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652010 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 14 | [SID51090468] | Active | | | Luminescence-based cell-based primary high throughput confirmation assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 [AID652134, Type: screening] | NR0B1 gene product [Homo sapiens] [gi:5016090] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput confirmation assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1 | | AID | 652134 | | BioAssay type | screening | | Target | NR0B1 gene product [Homo sapiens] [gi:5016090] | | PubMed | | | Data Table |  |
|
| 15 | [SID51090468] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 16 | [SID51090468] | Active | | | A qHTS for Small Molecule Inhibitors of Shiga Toxin [AID2315, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | A qHTS for Small Molecule Inhibitors of Shiga Toxin | | AID | 2315 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 17 | [SID51090468] | Active | | | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay [AID652136, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay | | AID | 652136 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 18 | [SID51090468] | Active | | | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay [AID652136, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay | | AID | 652136 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 19 | [SID51090468] | Active | | | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay [AID652136, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): Luminescence-based cell-based high throughput assay for nonselective inhibitors/assay artifacts using AP2 mutant SF-1 (NR5A1) Transactivation Assay | | AID | 652136 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 20 | [SID51090468] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 21 | [SID51090468] | Active | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 22 | [SID51090468] | Active | | | Luminescence-based confirmation biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) [AID1846, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Luminescence-based confirmation biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1846 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 23 | [SID51090468] | Active | | | Luminescence-based confirmation biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) [AID1846, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Luminescence-based confirmation biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1846 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 24 | [SID51090468] | Active | | | Luminescence-based confirmation biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) [AID1846, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Luminescence-based confirmation biochemical high throughput screening assay for inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1846 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 25 | [SID51090468] | Active | | | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) [AID1789, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1789 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 26 | [SID51090468] | Active | | | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) [AID1789, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1789 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 27 | [SID51090468] | Active | | | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) [AID1789, Type: screening] | HSP90AA1 protein [Homo sapiens] [gi:83318444] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Luminescence-based primary biochemical high throughput screening assay to identify inhibitors of the Heat Shock Protein 90 (HSP90) | | AID | 1789 | | BioAssay type | screening | | Target | HSP90AA1 protein [Homo sapiens] [gi:83318444] | | PubMed | | | Data Table |  |
|
| 28 | [SID51090468] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID51090468] | Active | | | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication [AID1885, Type: screening] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication | | AID | 1885 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID51090468] | Active | | | Luminescence-based counterscreen assay for HSP90 inhibitors: biochemical high throughput screening assay to identify inhibitors of native luciferase. [AID1847, Type: screening] | |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Active | | BioAssay | Luminescence-based counterscreen assay for HSP90 inhibitors: biochemical high throughput screening assay to identify inhibitors of native luciferase. | | AID | 1847 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 31 | [SID51090468] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 32 | [SID51090468] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 33 | [SID51090468] | Inactive | Potency | 1.3115 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | Potency | 1.3115 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 34 | [SID51090468] | Inactive | Potency | 9.285 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | Potency | 9.285 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 35 | [SID51090468] | Inactive | Potency | 16.4816 | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 [AID2288, Type: confirmatory] | |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | Potency | 16.4816 [uM] | | BioAssay | qHTS Assay for Modulators of miRNAs and/orActivators of miR-21 | | AID | 2288 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 36 | [SID51090468] | Inactive | Potency | 35.4813 | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) [AID485341, Type: confirmatory] | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Inhibitors of AmpC Beta-Lactamase (assay without detergent) | | AID | 485341 | | BioAssay type | confirmatory | | Target | Chain A, Ampc Beta-Lactamase In Complex With 4-Methanesulfonylamino Benzoic Acid [gi:119389684] | | PubMed | | | Data Table |  |
|
| 37 | [SID51090468] | Inactive | EC50 | 60 | Luminescence Cell-Based Dose Response HTS Screen to Identify Cytotoxic Compounds of NIH3T3 cells. [AID2010, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | EC50 | 60 [uM] | | BioAssay | Luminescence Cell-Based Dose Response HTS Screen to Identify Cytotoxic Compounds of NIH3T3 cells. | | AID | 2010 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID51090468] | Inactive | Potency | 100 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | Potency | 100 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 39 | [SID51090468] | Inactive | Potency | 100 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | Potency | 100 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 40 | [SID51090468] | Inactive | | | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity [AID493131, Type: screening] | protein fosB [Mus musculus] [gi:6679827] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | BioAssay | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity | | AID | 493131 | | BioAssay type | screening | | Target | protein fosB [Mus musculus] [gi:6679827] | | PubMed | | | Data Table |  |
|
| 41 | [SID51090468] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 42 | [SID51090468] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 43 | [SID51090468] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 44 | [SID51090468] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 45 | [SID51090468] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 46 | [SID51090468] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 47 | [SID51090468] | Inactive | Potency | | qHTS of IL-2 Activators [AID652025, Type: confirmatory] | Il2 gene product [Mus musculus] [gi:7110653] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of IL-2 Activators | | AID | 652025 | | BioAssay type | confirmatory | | Target | Il2 gene product [Mus musculus] [gi:7110653] | | PubMed | | | Data Table |  |
|
| 48 | [SID51090468] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 49 | [SID51090468] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 50 | [SID51090468] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 51090468 | | CID | 24892653 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|